Meta facebook tracking pixel

Listen Now

Topics Covered

  • HER2-Positive Metastatic Breast Cancer
  • Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
  • Standard Treatment Options, Including Targeted Therapy
  • How Biomarker Testing Informs Treatment Decisions
  • New & Emerging Targeted Treatments
  • Updates on Investigational New Drugs in Clinical Trials
  • How Research Contributes to Your Treatment Options
  • What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
  • Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Julie G. Fisher, MD

Medical Director, Levine Cancer Institute, Co-Director, Sandra Levine Young Women’s Breast Cancer Program, Associate Hematology/Oncology Fellowship Director, Levine Cancer Institute

Presenter

Dame Idossa, MD

Assistant Professor of Medicine, Breast Oncologist, Division of Hematology and Oncology, University of Minnesota

Presenter

Shimoli V. Barot, MD

Associate Staff, Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Center

Presenter

Saba Shaikh, MD

Assistant Professor, Division of Hematology/Oncology, Mays Cancer Center at UT Health San Antonio, MD Anderson Cancer Center

Presenter

Cassie Spector, MSW

Breast and Gynecological Cancers Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on April 24, 2024.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.